Characterization of copper-resistant bacteria and bacterial communities from copper-polluted agricultural soils of central Chile

Por Altimira, Fabiola, Yáñez, Carolina, Bravo, Guillermo, González, Myriam, Rojas, Luis A, Seeger, Michael
Publicado em 2012

Integrating Genetics and Epigenetics In MDS: Advances in Pathogenesis and Disease Evolution

Por Bravo, Guillermo Montalbán, Lee, Elinor, Merchan, Bryan, Kantarjian, Hagop M., García-Manero, Guillermo
Publicado no Br J Haematol (2014)

Lymphocyte recovery and infused CD34+ cells dose: Effect on the evolution after stem cell autotransplantation

Por Romero Fernández, Esperanza, Bravo, Guillermo Montalbán, Gallastegui, Rosario Arrieta, De la Rúa Fernández, Ana Rodríguez
Publicado em 2013

Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents

Por Alfonso, Ana, Montalban-Bravo, Guillermo, Takahashi, Koichi, Jabbour, Elias J., Kadia, Tapan, Ravandi, Farhad, Cortes, Jorge, Estrov, Zeev, Borthakur, Gautam, Pemmaraju, Naveen, Konopleva, Marina, Bueso-Ramos, Carlos, Pierce, Sherry, Kantarjian, Hagop, Garcia-Manero, Guillermo
Publicado no Am J Hematol (2017)

More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia

Por Montalban-Bravo, Guillermo, Benton, Christopher B., Wang, Sa A., Ravandi, Farhad, Kadia, Tapan, Cortes, Jorge, Daver, Naval, Takahashi, Koichi, DiNardo, Courtney, Jabbour, Elias, Borthakur, Gautam, Konopleva, Marina, Pierce, Sherry, Bueso-Ramos, Carlos, Patel, Keyur, Kornblau, Steven, Kantarjian, Hagop, Young, Ken H., Garcia-Manero, Guillermo, Andreeff, Michael
Publicado no Blood (2017)

Phase II Randomized Double-Blinded Study of Pracinostat in Combination with Azacitidine in Patients with Untreated Higher-Risk Myelodysplastic Syndromes

Por Garcia-Manero, Guillermo, Montalban-Bravo, Guillermo, Berdeja, Jesus G., Abaza, Yasmin, Jabbour, Elias, Essell, James, Lyons, Roger M., Ravandi, Farhad, Maris, Michael, Heller, Brian, DeZern, Amy E., Babu, Sunil, Wright, David, Anz, Bertrand, Boccia, Ralph, Komrokji, Rami S., Kuriakose, Philip, Reeves, James, Sekeres, Mikkael A., Kantarjian, Hagop, Ghalie, Richard, Roboz, Gail J
Publicado no Cancer (2017)

Randomized phase 2 study of low-dose decitabine vs low-dose azacitidine in lower-risk MDS and MDS/MPN

Por Jabbour, Elias, Short, Nicholas J., Montalban-Bravo, Guillermo, Huang, Xuelin, Bueso-Ramos, Carlos, Qiao, Wei, Yang, Hui, Zhao, Chong, Kadia, Tapan, Borthakur, Gautam, Pemmaraju, Naveen, Sasaki, Koji, Estrov, Zeev, Cortes, Jorge, Ravandi, Farhad, Alvarado, Yesid, Komrokji, Rami, Sekeres, Mikkael A., Steensma, David P., DeZern, Amy, Roboz, Gail, Kantarjian, Hagop, Garcia-Manero, Guillermo
Publicado no Blood (2017)

Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neopl...

Por Montalban-Bravo, Guillermo, Takahashi, Koichi, Patel, Keyur, Wang, Feng, Xingzhi, Song, Nogueras, Graciela M., Huang, Xuelin, Pierola, Ana Alfonso, Jabbour, Elias, Colla, Simona, Gañan-Gomez, Irene, Borthakur, Gautham, Daver, Naval, Estrov, Zeev, Kadia, Tapan, Pemmaraju, Naveen, Ravandi, Farhad, Bueso-Ramos, Carlos, Chamseddine, Ali, Konopleva, Marina, Zhang, Jianhua, Kantarjian, Hagop, Futreal, Andrew, Garcia-Manero, Guillermo
Publicado no Oncotarget (2018)

TP53 Mutation Does Not Confer a Poor Outcome in Adult ALL Treated with Frontline Hyper-CVAD-based Regimens

Por Kanagal-Shamanna, Rashmi, Jain, Preetesh, Takahashi, Koichi, Short, Nicholas J., Tang, Guilin, Issa, Ghayas C., Ravandi, Farhad, Garcia-Manero, Guillermo, Yin, Cameron C., Luthra, Rajyalakshmi, Patel, Keyur P., Khoury, Joseph D., Montalban-Bravo, Guillermo, Sasaki, Koji, Kadia, Tapan M., Borthakur, Gautam, Konopleva, Marina, Jain, Nitin, Garris, Rebecca, Pierce, Sherry, Wierda, William, Estrov, Zeev, Cortes, Jorge, O’Brien, Susan, Kantarjian, Hagop, Jabbour, Elias
Publicado no Cancer (2017)